Compound Profile: Phexin
Phexin 250 mg Glaxosmithkline is a cephalexin antibiotic preparation manufactured by GlaxoSmithKline for laboratory research applications. This first-generation cephalosporin compound belongs to the beta-lactam antibiotic class and provides researchers with a standardised pharmaceutical-grade reference material for antimicrobial studies. Scientists investigating bacterial cell wall synthesis mechanisms and antibiotic resistance patterns frequently examine cephalexin preparations in controlled laboratory environments.
Research laboratories studying gram-positive bacterial strains often utilise cephalexin formulations to investigate antimicrobial activity profiles. The compound’s well-characterised pharmacological properties make it valuable for comparative studies examining antibiotic efficacy across different bacterial species. Researchers at Stroid UK Shop can access this pharmaceutical-grade preparation for comprehensive antimicrobial research protocols.
Research Applications
Laboratory investigations commonly examine cephalexin’s bactericidal mechanism of action against susceptible organisms. The compound inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, disrupting peptidoglycan cross-linking processes essential for bacterial cell integrity. Research applications include antimicrobial susceptibility testing, minimum inhibitory concentration determinations, and bacterial resistance mechanism studies.
Microbiologists evaluate cephalexin preparations when investigating beta-lactam antibiotic interactions with bacterial enzyme systems. The compound serves as a reference standard for studies examining bacterial beta-lactamase production and antibiotic resistance development patterns. Researchers exploring novel antimicrobial strategies often compare experimental compounds against established cephalexin benchmarks. Additional research areas include pharmaceutical formulation studies and antibiotic stability investigations under various laboratory conditions.
Academic institutions studying infectious disease models frequently incorporate cephalexin preparations into their research protocols. The compound’s established safety profile and well-documented antimicrobial spectrum make it suitable for educational laboratory exercises examining antibiotic mechanisms. Researchers can explore advanced topics including selective androgen receptor modulators and peptide therapeutics alongside traditional antimicrobial research when developing comprehensive study programmes.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Cephalexin 250 mg |
| Manufacturer | GlaxoSmithKline |
| Form | Capsule/Tablet |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage | Room temperature, dry conditions |
| Intended Use | In-vitro research only |
Quality control documentation accompanies each research preparation, providing batch-specific analytical data for laboratory verification procedures. Researchers should store preparations according to manufacturer specifications and maintain proper chain of custody documentation for regulatory compliance.
Research Compliance
This Phexin 250 mg preparation is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical use, or therapeutic applications. Researchers must comply with all applicable laboratory safety protocols and institutional guidelines when handling pharmaceutical preparations. Products in our uncategorized research chemicals collection require appropriate laboratory facilities and qualified personnel for safe handling and study procedures.
